M Notes on the design of bioequivalence study: abacavir/lamivudine/lopinavir/ritonavir PDF Guideline/guidance
M Notes on the design of bioequivalence study: dihydroartemisinin + piperaquine tetraphosphate PDF Guideline/guidance
M Notes on the Design of Bioequivalence Study: Emtricitabine/Tenofovir Alafenamide/Dolutegravir PDF Guideline/guidance
M Notes on the Design of Bioequivalence Study: Emtricitabine/Tenofovir Disoproxil Fumarate /Dolutegravir PDF
M Notes on the design of bioequivalence study: emtricitabine/tenofovir disoproxil fumarate/ levonorgestrel/Ethinyl estradiol PDF Guideline/guidance
M Notes on the design of bioequivalence study: Emtricitabine/Tenofovir Disoproxil Fumarate/Efavirenz PDF
M Notes on the design of bioequivalence study: emtricitabine/tenofovir/dolutegravir PDF Guideline/guidance
M Notes on the design of bioequivalence study: emtricitabine/tenofovir/efavirenz PDF Guideline/guidance
M Notes on the design of bioequivalence study: ethambutol/isoniazid/pyrazinamide/rifampicin PDF Guideline/guidance
M Notes on the design of bioequivalence study: ethambutol/isoniazid/rifampicin PDF Guideline/guidance
M Notes on the design of bioequivalence study: ethinylestradiol/levonorgestrel PDF Guideline/guidance